Значок книги

Comparison of clinical outcomes between the depot gonadotrophin-releasing hormone agonist protocol and gonadotrophin-releasing hormone antagonist protocol in normal ovarian responders

Abstract Background The gonadotrophin-releasing hormone (GnRH) antagonist protocol has some advantages, such as a simple method, short medication duration, and low incidence of ovarian hyperstimulation syndrome, but whether the GnRH antagonist protocol is suitable for normal ovarian responders has b...

Полное описание

Сохранить в:

Библиографические подробности
Главные авторы:	Min Xia (Автор), Jie Zheng (Автор)
Формат:	‌
Опубликовано:	BMC, 2021-05-01T00:00:00Z.
Предметы:	article
Online-ссылка:	Connect to this object online.
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!

Схожие документы

Gonadotrophin releasing hormone antagonist in IVF/ICSI
по: M S Kamath, и др.
Опубликовано: (2008)

The effect of gonadotrophin-releasing hormone agonist versus human chorionic gonadotrophin trigger on pregnancy and neonatal outcomes in Letrozole-HMG IUI cycles
по: Li Chen, и др.
Опубликовано: (2023)

Myopic Progression in Girls with Gonadotrophin-Releasing Hormone Agonist Treatment for Central Precocious Puberty
по: Seung Ah Chung, и др.
Опубликовано: (2021)

Interplay between nitric oxide and gonadotrophin-releasing hormone in the neuromodulation of the corpus luteum during late pregnancy in the rat
по: Sandra Vallcaneras, и др.
Опубликовано: (2022)

Gonadotrophins: The future
по: Madhuri Patil
Опубликовано: (2014)

Efficacy of luteal estrogen administration and an early follicular Gonadotropin-releasing hormone antagonist priming protocol in poor responders undergoing fertilization
по: Hwajeong Lee, и др.
Опубликовано: (2018)

A three-arm randomised controlled trial comparing Gonadotrophin Releasing Hormone (GnRH) agonist long regimen <it>versus </it>GnRH agonist short regimen <it>versus </it>GnRH antagonist regimen in women with a history of poor ovarian response undergoing in vitro fertilisation (IVF) treatment: Poor responders intervention trial (PRINT)
по: Braude Peter, и др.
Опубликовано: (2007)

Influence of human chorionic gonadotrophin during ovarian stimulation: an overview
по: Johan Smitz, и др.
Опубликовано: (2020)

Comparative multiplex analysis of cytokines, chemokines and growth factors in follicular fluid of normoresponder women undergoing ovum donation with gonadotropin-releasing hormone agonist versus gonadotropin-releasing hormone antagonist protocols
по: Neena Malhotra, и др.
Опубликовано: (2013)

Luteinizing hormone changes in gonadotropin-releasing hormone antagonist protocol in in vitro fertilization cycles: A cross-sectional study
по: Batool Hosein Rashidi, и др.
Опубликовано: (2019)

Fresh versus frozen embryo transfer after gonadotropin-releasing hormone agonist trigger in gonadotropin-releasing hormone antagonist cycles among high responder women: A randomized, multi-center study
по: Abbas Aflatoonian, и др.
Опубликовано: (2018)

Does the "delayed start" protocol with gonadotropin-releasing hormone antagonist improve the pregnancy outcome in Bologna poor responders? a randomized clinical trial
по: Mahnaz Ashrafi, и др.
Опубликовано: (2018)

Effect of Flexible Half-Dose Gonadotropin-Releasing Hormone Antagonist Protocol on in vitro Fertilization Outcome in Predicted Normal Responder: A Study Protocol for a Multicentered, Randomized, Non-Inferiority, Parallel Controlled Trial
по: Ma YJ, и др.
Опубликовано: (2023)

Short-term efficacy of 1-month and 3-month gonadotropin-releasing hormone agonist depots in girls with central precocious puberty
по: Min Jin Jeon, и др.
Опубликовано: (2021)

Hormonal induction of spawning in 4 species of frogs by coinjection with a gonadotropin-releasing hormone agonist and a dopamine antagonist
по: Wignall Jacqui, и др.
Опубликовано: (2010)

Effect of gonadotropin-releasing hormone agonist on ES-2 ovarian cancer cells
по: Kuan-Hao Tsui, и др.
Опубликовано: (2014)

Long-Acting Luteinizing Hormone-Releasing Hormone Agonist for Ovarian Hyperstimulation Induced by Tamoxifen for Breast Cancer
по: Nobue Kojima, и др.
Опубликовано: (2018)

Fixed versus Flexible Gonadotropin Releasing Hormone Antagonist Protocol in Controlled Ovarian Stimulation for Invitro Fertilization in Women with Polycystic Ovary Syndrome
по: Batool Hossein Rashidi, и др.
Опубликовано: (2015)

EXPERIENCE OF CONDUCTING PREGNANCY AT THE SENSITIZATION TO THE HORIONICHESKY GONADOTROPHIN OF THE PERSON
по: Z. M. Dubossarskaya, и др.
Опубликовано: (2016)

Comparative proteomics reveal negative effects of gonadotropin-releasing hormone agonist and antagonist on human endometrium
по: Chen Q, и др.
Опубликовано: (2019)

Scheduling cycles with gonadotropin-releasing hormone antagonist protocol in in vitro fertilization: Is there a scope in batch in vitro fertilization?
по: Rohit Gutgutia, и др.
Опубликовано: (2014)

Fertility outcomes in women after controlled ovarian stimulation with gonadotropin releasing hormone agonist long protocol: fresh versus frozen embryo transfer
по: Xiaoyan Ding, и др.
Опубликовано: (2021)

Diminished ovarian reserve predisposes to premature luteinizing hormone surges in gonadotropin-releasing hormone antagonist cycles in In vitro fertilization
по: Puneet Kaur Kochhar, и др.
Опубликовано: (2020)

Antiproliferative effect of growth hormone-releasing hormone (GHRH) antagonist on ovarian cancer cells through the EGFR-Akt pathway
по: Varga Jozsef, и др.
Опубликовано: (2010)

Selection of gonadotrophin surge attenuating factor phage antibodies by bioassay
по: Mason Helen D, и др.
Опубликовано: (2005)

Artificial Endometrial Preparation for Frozen-Thawed Embryo Transfer with or without Pretreatment with Depot Gonadotropin Releasing Hormone Agonist in Women with Regular Menses.
по: Elham Azimi Nekoo, и др.
Опубликовано: (2015)

Increasing dominant follicular proportion negatively associated with good clinical outcomes in normal ovarian responders using the depot GnRH agonist protocol: a large-sample retrospective analysis
по: Houming Su, и др.
Опубликовано: (2022)

Pregnancy outcome in long- versus short-acting gonadotropin-releasing hormone agonist cycles in participants with normal ovarian reserve: An RCT
по: Roya Kabodmehri, и др.
Опубликовано: (2023)

Clinical development of the oral gonadotropin-releasing hormone antagonist elagolix
по: Kristof Chwalisz, M.D., Ph.D
Опубликовано: (2023)

Fixed versus flexible gonadotropin releasing hormone antagonist protocol in women with polycystic ovary syndrome undergoing in vitro fertilization: An RCT
по: Hanieh Fatehi, и др.
Опубликовано: (2024)

NTPDases in the neuroendocrine hypothalamus: Possible energy regulators of the positive gonadotrophin feedback
по: Zsarnovszky Attila, и др.
Опубликовано: (2009)

Modulation of gonadotrophin induced steroidogenic enzymes in granulosa cells by d-chiroinositol
по: Sandro Sacchi, и др.
Опубликовано: (2018)

Differentiation of adult-type Leydig cells occurs in gonadotrophin-deficient mice
по: Charlton HM, и др.
Опубликовано: (2003)

Possible Improvement of Oocyte Supply by the use of Aged Mice and Different Gonadotrophins
по: Myungook Lee, и др.
Опубликовано: (2018)

Gonadotropin-Releasing Hormone Agonist Combined with Hormone Replacement Therapy Protocol Improves the Live Birth Rate in Frozen-Thawed Embryo Transfer Cycles for Patients without Endometriosis
по: Yu Wang, и др.
Опубликовано: (2023)

Incidence and severity of ovarian hyperstimulation syndrome (OHSS) in high responders after gonadotropin-releasing hormone (GnRH) agonist trigger in "freeze-all" approach
по: M. Fernández-Sánchez, и др.
Опубликовано: (2023)

Meta-analysis of trigger timing in normal responders undergoing GnRH antagonist ovarian hyperstimulation protocol
по: Qijun Xie, и др.
Опубликовано: (2024)

Potential Mechanisms of Ovarian Protection with Gonadotropin-Releasing Hormone Agonist in Breast Cancer Patients: A Review
по: Francesca Poggio, и др.
Опубликовано: (2019)

Application value of Early-Follicular Phase Long-Acting Gonadotropin-Releasing Hormone Agonist Long Protocol in patients with resistant ovary syndrome
по: Fan Zhang, и др.
Опубликовано: (2023)

Economic evaluation of highly purified human menotropin or recombinant follicle-stimulating hormone for controlled ovarian stimulation in high-responder patients: analysis of the Menopur in Gonadotropin-releasing Hormone Antagonist Single Embryo Transfer-High Responder (MEGASET-HR) trial
по: Jared C. Robins, M.D, и др.
Опубликовано: (2020)